RE: Avacta on its shortlisting in the European Mediscience Awards 20247 May 2024 15:47
I note that it highlights:
*****************************
The chart shows the FAP level is not the limiting factor on whether Dox gets into the TME as per Mid and High cases.
The presence of FAP is all that is required to cleave = the scope of Pre|CISION could be any FAP tumour using the best warhead for that indication
***********************
Which I said was the best slide in that presentation and why I am still keeping the faith just about.
Who is BMHLTD?